India may deploy Covid-19 vaccine boosters: Brazil, South Africa unlikely to follow soon
There’s increasing talk of vaccine boosters to combat the Delta variant. But what does this mean in COVID-19 hotspots such…
By
Brazil
Latest in
Brazil
ARCA biopharma expands Phase IIb Covid-19 drug trial to South America
The global trial will evaluate two dosing regimens of rNAPc2 against heparin in hospitalised Covid-19 patients.
Eiger starts dosing in Phase III Covid-19 drug trial in outpatients
Licenced from Bristol-Myers Squibb, IFN lambda can potentially hinder viral replication without developing cytokine storms.
J&J’s Covid-19 vaccine exhibits activity against Delta variant
The vaccine elicited a higher level of activity against the Delta variant compared to the Beta variant of the SARS-CoV-2…
Evergreen and ICON partner for Phase II Covid-19 drug trial
ICON will act as Evergreen’s CRO to aid in trial management and will conduct the medical testing activities.
Appili to conduct Covid-19 treatment trial in Mexico and Brazil
Site activation is underway in Mexico while the process is anticipated to commence soon in Brazil.
Pfizer’s tofacitinib lowers mortality in Covid-19 pneumonia trial in Brazil
By day 28, subjects receiving tofacitinib had an 18.1% reduction in the cumulative occurrence of death or respiratory failure.
Sinovac’s Covid-19 vaccine lowers deaths by 95% in first mass trial
Data from Brazil's mass Covid-19 trial showed that symptomatic cases reduced by 80% and hospitalisations dropped by 86%.